Telepatia AI

Market position

Positioned as a Latin America-focused clinical AI company, described in coverage as having secured one of the largest digital health investments raised by a Latin American company via its US$33M Series A. The company frames its market opportunity around structural clinician shortages in the region (cited as roughly 43% fewer doctors and 65% fewer nurses per capita than the OECD average), roughly $700B in annual regional healthcare spending with about 1% going to software, and clinicians spending 40–70% of their time on non-care tasks (sources 4, 6).

The company emphasizes integration with more than 50 existing hospital record systems — including Epic and Hosvital — so institutions need not migrate infrastructure, distinguishing it from a standalone transcription tool. Other stated differentiators are a clinical advisor limited to peer-reviewed literature and institutional protocols rather than general web search, adaptation to each physician's documentation style, multilingual support for Spanish, Portuguese and English, free access for independent physicians, and a team composed largely of physicians and engineers recruited back to Latin America from institutions and companies including Stanford, Harvard, MD Anderson, Meta, Twitter/X and Microsoft (sources 0, 2, 4, 6, 7).

Technology

Speech-to-text transcription of clinical encounters with automatic generation of structured notes (including SOAP format) adapted to each clinician's style and each institution's documentation template; a retrieval-oriented clinical copilot that answers dosage, differential-diagnosis and management questions using scientific literature and institutional protocols; and integrations with more than 50 electronic health record systems, including Epic in the United States and Hosvital in Colombia. All AI output is presented as suggestions requiring physician review and approval (sources 0, 2, 3, 6, 7).

Go-to-market

Direct institutional sales in Latin America combined with bottom-up clinician adoption through free access for independent physicians and freely distributed mobile apps and a Chrome extension. The website offers an institutional intake form segmented by country (Colombia, Brazil, Peru, Mexico, Chile, Argentina) and institution type. Sales began in January 2025 while the founder was at Stanford, with the founder subsequently relocating to São Paulo (sources 0, 1, 2, 3, 4).

Physicians and nurses, and the institutions that employ them: clinics, hospitals, health networks, telemedicine platforms and health insurers/operators in Latin America. Deployments cited include Hospital Mater Dei (Brazil), Fundación Santa Fe de Bogotá (Colombia) and a rural pilot at Hospital San Roque in Guacarí, Colombia (sources 0, 6, 7).

Geography

Headquartered operationally in São Paulo, Brazil after the founder's move from Stanford; the company was founded in Medellín, Colombia and incubated at Stanford University, and Telepatia AI Inc. lists a US address at 735 Campus Dr, Stanford, California. Deployments span Brazil, Colombia, Mexico, Chile and Argentina, and the website also targets Peru; Chile was added as a supported patient country in a 2026 app release (sources 1, 2, 3, 4, 6, 7).

History

Telepatia began selling on January 20, 2025 while Abad was at Stanford. An iOS app version 1.0 was published in June 2025, followed by regular releases through version 1.5.0 in August 2026. By October 2025 the company reported more than 2,000 doctors across 15+ institutions, and it announced a $9M seed round led by A-Star that month. The founder relocated to São Paulo during 2025. In July 2026 the company announced a $33M Series A led by Andreessen Horowitz, taking total funding to $42M, and reported deployment in more than 25 institutions (sources 2, 4, 5, 6, 7).

Risks & controversies

Sources report no litigation or controversy. Notable diligence considerations from the material itself: most performance figures (time saved, protocol adherence, share of medical errors prevented, adoption rates) are company-reported and unaudited; sources disagree on the company's origin and base, describing it variously as a Brazilian healthtech, as founded in Medellín, Colombia and incubated at Stanford, and as a US-incorporated entity (Telepatia AI Inc., Stanford, California); institution counts differ across the July 2026 articles (more than 25 versus more than 30 institutions); consumer app distribution metrics are small relative to the claimed institutional footprint, and the Google Play listing shows a 3.4-star average and states that data is not encrypted, which sits alongside the company's stated end-to-end encryption and HIPAA/LGPD compliance claims (sources 0, 2, 3, 5, 6, 7).